GENFIT Stock Börse Stuttgart
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Börse Stuttgart
15:56:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 12.92 EUR | -5.28% |
|
-5.69% | +153.33% |
| Market Cap | 651M 756M 617M 559M 1.05B 72.22B 1.05B 7.32B 2.82B 36.74B 2.84B 2.78B 116B | P/E 2026 * |
33.5x | P/E 2027 * | 74.3x |
|---|---|---|---|---|---|
| Enterprise Value | 600M 697M 568M 515M 966M 66.55B 971M 6.75B 2.6B 33.86B 2.62B 2.56B 107B | EV / Sales 2026 * |
5.98x | EV / Sales 2027 * | 4.67x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| GNFT | Real-time | |
CBOE
| GNFTp | Real-time | |
|
Börse Stuttgart
| XUP | Delayed | |
|
Tradegate
| XUP | Real-time | |
|
OTC Markets
| GNFTF | Delayed | |
|
Deutsche Boerse AG
| XUP | Delayed | |
|
Boerse Muenchen
| XUP | Real-time | |
|
Xetra
| XUP | Delayed | |
|
London S.E.
| 0QT6 | Delayed | |
|
CBOE
| 0QT6 | Real-time |
Last Transcript : GENFIT
| 1 day | -5.28% | ||
| 1 week | -5.69% | ||
| Current month | -7.71% | ||
| 1 month | +2.38% | ||
| 3 months | +44.84% | ||
| 6 months | +44.76% | ||
| Current year | +153.33% |
| 1 week | 11.8 |  | 14.24 |
| 1 month | 11.8 | | 14.8 |
| Current year | 5.06 | | 15.4 |
| 1 year | 3.58 | | 15.4 |
| 3 years | 3.3 | | 15.4 |
| 5 years | 2.96 | | 15.4 |
| 10 years | 2.96 | | 21.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 2019-09-15 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 2021-04-21 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2017-06-15 | |
| Director/Board Member | 54 | 1999-09-14 | |
| Director/Board Member | 58 | 2017-06-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.28% | -5.69% | - | - | 797M | |
| -0.71% | -6.35% | -4.87% | +9.03% | 46.05B | |
| +0.21% | -2.98% | +340.68% | +519.93% | 43.59B | |
| +1.74% | -2.24% | +37.28% | +21.57% | 42.35B | |
| +1.38% | -3.28% | +3.23% | +65.60% | 38.86B | |
| -1.44% | -5.26% | +8.78% | +36.85% | 32.24B | |
| +0.87% | -2.60% | - | - | 17.16B | |
| +0.75% | -0.64% | +18.07% | +110.32% | 16.28B | |
| -0.31% | -2.78% | +10.47% | +30.49% | 14.32B | |
| +1.93% | -3.55% | +74.20% | +39.37% | 13.03B | |
| Average | -0.09% | -4.23% | +60.98% | +104.14% | 29.32B | |
| Weighted average by Cap. | +0.38% | -4.51% | +73.05% | +123.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 116M 94.96M 86.07M 161M 11.12B 162M 1.13B 434M 5.66B 437M 428M 17.88B | 125M 146M 119M 108M 202M 13.91B 203M 1.41B 542M 7.07B 547M 535M 22.36B |
| Net income | 22.88M 26.55M 21.66M 19.63M 36.84M 2.54B 37.02M 257M 98.94M 1.29B 99.72M 97.53M 4.08B | 6.8M 7.89M 6.44M 5.84M 10.95M 754M 11M 76.47M 29.41M 384M 29.64M 28.99M 1.21B |
| Net Debt | -51.11M -59.32M -48.39M -43.86M -82.29M -5.67B -82.7M -575M -221M -2.88B -223M -218M -9.11B | -65.86M -76.44M -62.36M -56.52M -106M -7.3B -107M -741M -285M -3.72B -287M -281M -11.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | €12.92 | -5.28% | 12,974 |
| 26-09-10 | €13.64 | +12.17% | 11,159 |
| 26-09-09 | €12.16 | -6.61% | 14,147 |
| 26-09-08 | €13.02 | -3.98% | 10,311 |
| 26-09-07 | €13.56 | -1.02% | 3,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
Select your edition
All financial news and data tailored to specific country editions
